title: [Measuring cesium 137 concentrations in surgical specimen of gynecologic tumors and breast milk, amniotic fluid and in umbilical cords, 6 years after Chernobyl].
abstract: In the present study, the cesium 137 content in various human tissues was examined 6 years after the Chernobyl reactor catastrophe. The measurements were performed with a gamma-ray spectrometer by means of a germanium/lithium detector. The median of cesium 137 was 20 mBq/ml in mother's milk, 60 mBq/ml in amniotic fluid, 105 mBq/g in umbilical cords, 51 mBq/g in ovarian tumours, and 140 mBq/g in mammary carcinomas. These values lay far below the permissible limit values of 528 mBq/ml or 528 mBq/g for persons not exposed to radiation. The problems of determining the upper limit were also discussed, and it was ascertained that despite the favorably low values recorded in this study a residual risk to health cannot be absolutely precluded in the light of present-day knowledge.
authors.affiliation: Institute für Klinische Pathologie der Universität Wien.
authors.forename: K F
authors.initials: KF
authors.lastname: Czerwenka
authors.forename: F
authors.initials: F
authors.lastname: Heuss
authors.forename: D K
authors.initials: DK
authors.lastname: Teherani
mesh_terms: D000653:Amniotic Fluid / Q000378:metabolism* / Q000528:radiation effects; D001822:Body Burden; D001940:Breast / Q000378:metabolism / Q000528:radiation effects; D001943:Breast Neoplasms / Q000378:metabolism*; D002588:Cesium Radioisotopes / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008895:Milk, Human / Q000378:metabolism* / Q000528:radiation effects; D010051:Ovarian Neoplasms / Q000378:metabolism*; D010053:Ovary / Q000378:metabolism / Q000528:radiation effects; D011210:Power Plants; D011247:Pregnancy; D011834:Radiation Monitoring; D018788:Radioactive Hazard Release; D014470:Umbilical Cord / Q000378:metabolism* / Q000528:radiation effects
chemical_list: D002588:Cesium Radioisotopes
vernacular_title: Messungen der Caesium 137-Konzentrationen in Operationspräparaten gynäkologischer Tumoren sowie in Muttermilch, Fruchtwasser und in Nabelschnüren, 6 Jahre nach Tschernobyl.